Non-type 2 airway inflammation in severe asthma: from bench to bedside
Severe asthma remains a major clinical challenge despite substantial advances in biologic therapies targeting type 2 inflammation. Whereas type 2-high asthma is increasingly well characterized and effectively treated, a considerable proportion of patie…